We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Self-Collection of Specimens for HPV Testing Is Feasible

By Biotechdaily staff writers
Posted on 11 Sep 2007
Although cytology-screening programs for human papillomavirus (HPV) are available in developed countries, not all women make full use of them. More...
The feasibility of using self-collected specimens for testing human papillomavirus (HPV) status among hard-to-reach women was studied in British Columbia.

Outreach nurses, recruited women in women's centers, shelters, and alleys in Vancouver's (Canada) downtown Eastside section. Participants were given a diagram that illustrated how to obtain a cervicovaginal specimen. They then placed the specimen in a tube containing Digene (Gaithersburg, MD, USA) specimen transport medium. Women were asked to collect the specimen immediately at the closest washroom or private location and to return it to the nurse.

Samples were transported to the British Columbia Center for Disease Control (Vancouver, British Columbia, Canada) within 24 hours of collection. They were analyzed for the presence of high-risk HPV DNA using the Digene HPV test, according to the manufacturer's instructions. Of the 151 participants whose specimens that were analyzed, 43 were positive for high-risk HPV. The women who tested positive were significantly younger; less educated, and reported having had more sex-trade partners than women who tested negative.

About 14% (21/151) of participants had never received a Papanicolaou smear in British Columbia (BC, Canada), as compared with 8.3% (608/7336) of women in the BC general population. This difference suggests that self-collection of specimens for HPV testing is a practical method to reach women who have not previously participated in cervical cancer screening programs.

The study was initiated by Dr. Gina Ogilvie, assistant professor, University of British Columbia (Vancouver, Canada) and was published in the August 2007 issue of the Canadian Medical Association Journal (CMAJ).


Related Links:
British Columbia Center for Disease Control
Digene
University of British Columbia

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Aspiration System
VACUSAFE
Electrolyte Analyzer
BKE-B
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Nian Sun has spent years perfecting a device that he believes could change the way diseases are detected. (Photo courtesy of Alyssa Stone/Northeastern University)

Rapid Breath Sensor Detects SARS-CoV-2 from Exhaled Air

Nasal swabs and polymerase chain reaction (PCR) testing have been central to identifying SARS-CoV-2, but they can be uncomfortable, slow, and logistically complex when samples require transport.... Read more

Molecular Diagnostics

view channel
Image: At the MHH Institute of Human Genetics: Prof. Dr. Doris Steinemann, Dr. Bernardus Aldrige Allister and Prof. Dr Monika Golas (from left). (Image Credit: Karin Kaiser/MHH)

Multi-Omics Analysis Identifies Additional Risk Genes in Hereditary Breast and Ovarian Cancer

Hereditary breast and ovarian cancer can be difficult to explain genetically, leaving many high-risk families without clear answers. Although 13 established risk genes, including BRCA1 and BRCA2, are routinely... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.